ObsEva Announces Update on Board of Directors

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel

Table Trac Announces Quarterly Dividend

MINNETONKA, Minn., March 18, 2024 (GLOBE NEWSWIRE) — On March 14, 2024, The Board of Directors of Table Trac Inc. (the “Company”) (OTCQX: TBTC) approved a cash dividend on the

Transgene Announces Upcoming Investor Meetings

Strasbourg, March 18, 2024 – 05:45 pm CET TRANSGENE (Paris: TNG) today announces that Management will participate in several investor events in the upcoming months, as set out below. Investor

Scroll to Top